Editors' ChoiceInfectious Disease

No one is naïve: Young infant’s immunity can dodge Darwinian selection

See allHide authors and affiliations

Science Translational Medicine  07 Feb 2018:
Vol. 10, Issue 427, eaar7530
DOI: 10.1126/scitranslmed.aar7530


Unlike adults, young infant antibody responses against respiratory syncytial virus are biased toward limited antigenic sites, suggesting a blueprint for future infant and age-specific vaccines.

View Full Text

Stay Connected to Science Translational Medicine